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KAHRPThe malaria parasite Plasmodium falciparum exports a large number of proteins into the erythrocyte cytoplasm
during the asexual intraerythrocytic stage of its life cycle. A subset of these proteins interacts with erythrocyte
membrane skeletal proteins and grossly alters the structure and function of the membrane. Several of the
exported proteins, such as PfEMP1, PfEMP3, RESA and KAHRP, interact with the preponderant erythrocyte skel-
eton protein, spectrin. Herewe have searched for possible interaction of these fourmalaria proteinswith another
major erythrocyte skeleton protein, ankyrin R.We have shown that KAHRP, but none of the other three, binds to
ankyrin R. We have mapped the binding site for ankyrin R to a 79-residue segment of the KAHRP sequence, and
the reciprocal binding site for KAHRP in ankyrin R to a subdomain (D3) of the 89 kDa ankyrin R membrane-
binding domain. Interaction of intact ankyrin R with KAHRP was inhibited by the free D3 subdomain. When,
moreover, red cells loaded with the soluble D3 subdomain were infected with P. falciparum, KAHRP secreted
by the intraerythrocytic parasite no longermigrated to the host cell membrane, but remained diffusely distribut-
ed throughout the cytosol. Ourﬁndings suggest a potentially important role for interaction of KAHRPwith red cell
membrane skeleton in promoting the adhesion of malaria-infected red cells to endothelial surfaces, a central el-
ement in the pathophysiology of malaria.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
Plasmodium falciparum causes the most severe form of human
malaria and is responsible for nearly all malaria-induced mortality.
During the asexual intraerythrocytic life cycle of P. falciparum, the
parasite exports a large number of proteins into the red cell cytoplasm,
some of which bind to the host membrane skeleton proteins [1–3]. The
resulting interactions induce extensive structural and functional changes
in the infected erythrocytes, notably increased adhesiveness to endothe-
lial surfaces, decreased membrane deformability and altered cell
morphology and elevated permeability to a wide variety of ions
[4–6]. To determine the mechanisms by which the parasite proteins
exert their effects on the host cell, we and others have sought to deﬁne
the nature of their interactions with the components of the host cellK 26263 and DK 32094, and by
Foundation of China.
ology, 310 E 67th St, New York,
3264.
ights reserved.membrane. To date, ﬁve P. falciparum proteins have been reasonably
well characterized, namely erythrocyte membrane-binding protein
1(PfEMP1), the erythrocyte membrane-binding protein 3 (PfEMP3),
the ring parasite-infected erythrocyte surface antigen (RESA), the
knob-associated histidine-rich protein (KAHRP), and the mature para-
site-infected erythrocyte surface antigen (MESA).
The erythrocyte membrane is a composite structure in which the
lipid bilayer with its integral proteins is linked to a two-dimensional
membrane skeleton network. The major skeleton proteins are α-
spectrin, β-spectrin, actin, protein 4.1R, ankyrin R, protein 4.2, p55,
adducin, dematin, tropomyosin, and tropomodulin [7–9]. The α- and
β-spectrins in the formof predominantlyα2β2 tetramers are the principal
components of themembrane skeletal network [10,11],which is attached
to the lipid bilayer through two pathways, both involving integral and pe-
ripheral protein constituents. One involves ankyrin R, which interacts
with the cytoplasmic domain of the preponderant transmembrane
protein, band 3, forming the “ankyrin R-complex”, which is attached
to the spectrin tetramers at a point near the point of apposition of the
two αβ dimers [12]. The other involves protein 4.1R which associates
with the transmembrane glycophorin C to form the “4.1R-complex” at
the spectrin–actin junctional complex at the network nodes [13].
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KAHRP, PfEMP1, PfEMP3 and MESA, all but MESA have been shown to
interact with spectrin. Each of these four proteins has its own separate
binding site in spectrin, and the consequences of their interactions are
accordingly distinguishable. While RESA binds to β-spectrin repeat 16,
close to the labile dimer–dimer self-association site, PfEMP3 binds to
the EF hands of α-spectrin at the distal ends of the tetramers. Conse-
quently, the RESA–spectrin interaction stabilizes the spectrin tetramer
against dissociation into its constituent dimers, thereby increasing
shear resistance of the membrane stability [14]. In contrast, PfEMP3 de-
stabilizes the membrane by dissociating the spectrin–actin–4.1 ternary
complex [15]. KAHRP binds to repeat 4 of α-spectrin. Although
KAHRP–α-spectrin association has no effect on the membrane me-
chanical properties, interaction of KAHRP with spectrin is required
for the proper assembly of KAHRP into the knob complex found at
the erythrocyte membrane [16].
In contrast to thewell-characterized interactions of malaria proteins
with spectrin, their relation to other major erythrocyte skeleton pro-
teins is less well understood. To date, MESA has been reported to
bind exclusively protein 4.1R [17–19]. In vivo studies support the
role of trafﬁcking and skeletal-binding motifs in the interaction of
MESA with the membrane skeleton of P. falciparum-infected red
blood cells [20]. MESA–4.1R interaction appears to be important for
intraerythrocytic growth of the parasite, since the invasion, growth
and viability of MESA(+) parasites is reduced in 4.1R-deﬁcient
erythrocytes [21,22].
We have previously reported a putative association between KAHRP
and ankyrin R based on immunoprecipitation of solubilized malaria-
infected red blood cells [23]. In that study an antibody against KAHRP
co-precipitated an 89 kDa protein fragment that was also recognized
by an anti-ankyrin R antibody. Because of the nature of such studies
an interaction can only be regarded as provisional. Also there was no
study to examine the functional consequences of such an association.
In the present study, we have searched for the interaction of malarial
proteins with ankyrin R that bridges the membrane skeleton to the
plasma membrane. We found that of the four malaria proteins we ex-
amined, only KAHRP bound to ankyrin R. We identiﬁed the ankyrin R-
binding site in KAHRP and the reciprocal KAHRP-binding site in ankyrin
R. The ankyrin R binding site is located within a 79 aa fragment of
KAHRP. The fragment binds to the D3 region in the membrane-
binding domain of ankyrin R. Furthermore, enclosure of the D3 poly-
peptide in erythrocytes before infection bymalarial parasites prevented
themigration of KAHRP to themembrane. These ﬁndings imply that the
interaction with ankyrin R is necessary for the attachment of KAHRP to
the host cell membrane.2. Material and methods
2.1. Materials
Type A fresh blood was obtained from healthy volunteers with
informed consent. Serum from type A blood donor was obtained
from the Interstate Blood Bank (Memphis, TN). Parasite clone 3D7
was obtained from MR4 (Manassas, VA). pGEX-4T-2 vector and
glutathione-Sepharose 4B were purchased from Amersham Biosci-
ences. pMAL-c2x vector, amylose resin and BL21(DE3) were from
New England Bio-Lab. The reduced form of glutathione, isopropyl-β-D-
galactopyranoside and Percoll were purchased from Sigma. Rabbit
anti-ankyrin R, anti-KAHRP, anti-MBP and anti-GST antibodies were
produced by our laboratory. HRP-conjugated anti-rabbit IgG was
from Jackson Immuno Research Laboratory (West Grove, PA). FITC-
conjugated donkey anti-rabbit IgG was from Invitrogen (Carlsbad,
CA). The CM-5 sensor chip, amino coupling kit, and other reagents
for SPR assay were purchased from BIAcore (Piscataway, NJ). All
other chemicals were reagent grade products from standard sources.2.2. Recombinant malaria and ankyrin R fragments
The recombinant GST-tagged KAHRP fragments (K1A, K1B, K1C,
K1D, K2 and K3), MBP-tagged RESA fragments (F1, F2, F3, F4, F5, F6
and F7), GST-tagged PfEMP3 fragments (FIa, FIb, FII, FIII, FIV and
FV), and GST-tagged cytoplasmic domain of PfEMP1 (VARC) have
been previously described [14–16,24,25]. The three functional do-
mains of ankyrin R (N-terminal 89 kDa membrane binding domain,
internal 62 kDa spectrin-binding domain and C-terminal 55 kDa
regulatory domain) and the subdomains of the membrane-binding
domain (D1, D2, D3 and D4) were sub-cloned into pMAL-c2x vector
using EcoRI and SalI upstream and downstream respectively. cDNA
from human erythroblasts cultured from CD34+ cells was used as
template for amplifying ankyrin fragments. The ﬁdelity of all the
constructs was veriﬁed by DNA sequencing.
2.3. Preparation of ankyrin R and recombinant proteins
Full length ankyrin Rwas puriﬁed from the red blood cells according
to the method described by Tyler et al. [26]. To obtain recombinant
proteins, cDNA encoding the desired polypeptide was transformed
into the BL21 bacteria strain. The expression of recombinant proteins
was induced by 0.1 mM isopropyl β-D-thiogalactopyranoside at
16 °C overnight. The GST-tagged polypeptides were puriﬁed using
a glutathione-Sepharose 4B afﬁnity column. The MBP-tagged poly-
peptides were puriﬁed on an amylose resin afﬁnity column. Proteins
were dialyzed against PBS (10 mM phosphate, pH 7.4, 150 mM
NaCl) for pull-down assays, against HBS-EP buffer (20 mM HEPES,
pH7.4, 150 mMNaCl, 3 mM EDTA, and 0.05% surfactant P20) for sur-
face plasmon resonance assay, or against hypotonic buffer (5 mM
Tris, 5mMKCl, pH7.4) for resealing. Protein concentrations were de-
termined by BCA kit (Thermo scientiﬁc, CA), using BSA as standard.
All the proteins were clariﬁed by ultracentrifugation at 230,000 g
for 30 min at 4 °C before use.
2.4. Pull-down assays
To examine the binding of full-length ankyrin R to malaria pro-
teins, recombinant GST-tagged KAHRP polypeptides, GST-tagged
PfEMP3 polypeptides and the GST-tagged cytoplasmic domain of
PfEMP1 were coupled to glutathione-Sepharose 4B beads in a total
volume of 100 μl (at the concentration of 1 μM) at room temperature
for 30 min. MBP-tagged RESA fragments were coupled to amylase
beads. Beads were pelleted and washed, then ankyrin R, at a concen-
tration 1 μM in a volume of 100 μl, was added to the beads. The mix-
ture was incubated for 1 h at room temperature, pelleted, washed,
and eluted with 10% SDS. The pellet was analyzed by SDS-PAGE.
The binding of ankyrin R to KAHRP fragments was detected byWest-
ern blot analysis using an anti-ankyrin R antibody. To examine the
binding between recombinant KAHRP fragments and ankyrin R frag-
ments, MBP-tagged ankyrin R fragments were coupled to amylose
beads. After washing, GST-tagged KAHRP K1D fragment was added.
The binding was detected by Western blot using an anti-GST anti-
body. Equal coupling of each tagged protein to the beads was validat-
ed by SDS-PAGE followed by CBB staining.
2.5. Enzyme-linked immunosorbent assay (ELISA)
ELISA was used for detecting direct binding between ankyrin R
and KAHRP and for the inhibition assay. To examine the binding of
full length ankyrin R to GST-tagged KAHRP fragments, full length
ankyrin R (0. 1 μM) was coated on the 96-well plate overnight at
4 °C. The plate was washed and blocked with 1% BSA in PBS, with
0.05% Tween 20, for 1 h at room temperature. GST-tagged K1A,
K1B, K1C, K1D, K2 and K3 (each 0. 1 μM) was added and the reaction
was continued for another 30 min. The binding of GST-tagged K1D
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For inhibition assay, full length ankyrin R (0. 1 μM)was coated on the
96-well plate overnight at 4 °C. The platewaswashed and blockedwith
1% BSA in PBS, with 0.05% Tween 20, for 1 h at room temperature. GST-
tagged K1D (0.1 μM) pre-incubated with various concentrations
(0 μM−8 μM) ofMBP-D3 (MBP as control)was added and the reaction
was continued for another 30 min. The binding of GST-tagged K1Dwas
detected by an anti-GST antibody. The plate was read at 450 nm.
2.6. Surface plasmon resonance assay
Surface plasmon resonance assay was performed using a BIAcore
3000 instrument. GST-tagged K1D fragment of KAHRP (1 μM) was
covalently coupled to a CM-5 biosensor chip using an amino coupling
kit. Binding reactions were done in HBS-EP buffer, containing 20 mM
HEPES, pH 7.4, 150 mM NaCl, 3 mM EDTA, and 0.05% (v/v) surfac-
tant P20. The surface was regenerated before each new injection
using 50 mM NaOH. The BIAcore instrument was programmed to
perform a series of binding assays with increasing concentrations
of MBP-MBD and MBP-D3 polypeptide over the same regenerated
surface. Sensograms (plots of changes in response unit on the surface
as a function of time) derived were analyzed using the software
BIAeval 3.0. Afﬁnity constants were estimated by curve ﬁtting using
a 1:1 binding model.
2.7. Resealing of erythrocytes
To introduce MBP, or MBP-tagged D3 into erythrocytes, the washed
erythrocytes were lysed and resealed using the dialysis method [14,27].
Brieﬂy, 2 ml of packed erythrocytes (in a dialysis tube, in the absence or
presence of desired polypeptides) at a 50% hematocrit was dialyzed
against 500 ml of cold hypotonic buffer (5 mM KPO4, pH 7.4, 20 mM
KCl) for 80 min at 4 °C. The isotonicity was restored, and erythrocytes
were resealed by dialyzing the lysed cells against 500 ml of pre-
warmed isotonic buffer (5 mM KPO4, 160 mM KCl, 5 mM glucose) for
60 min at 37 °C.
2.8. Invasion of erythrocytes by malaria parasites
The 3D7 clone parasite was maintained using standard procedures
in RPMI 1640 medium [28]. Sorbitol synchronization of P. falciparum-
infected erythrocytes was performed as described before [29]. The syn-
chronized infected cells were puriﬁed using Percoll gradients to nearly
100% purity [30]. The fraction containing mature trophozoite-infected
erythrocytes was added to resealed erythrocytes at a starting
parasitemia of 2%. The cells were cultured using standard procedures
in RPMI 1640medium for 48 h. At the end of the culture, the infected
erythrocytes were separated by Percoll gradient, and the puriﬁed
late stage infected cells were examined by confocal microscopy.
2.9. Immunoﬂuorescence staining and confocal microscopy
Preparation of erythrocytes for immunoﬂuorescencewas performed
as previously described [16,31]. Cells were permeabilized in PBS con-
taining 0.1 M glycine (rinsing buffer) and 0.1% Triton-X100 for 5 min
followed by three rinses with rinsing buffer. Nonspeciﬁc binding was
blocked by incubation for at least 60 min in blocking buffer (PBS con-
taining 0.05 mM glycine, 0.2% ﬁsh skin gelatin, and 0.05% sodium
azide). Staining of ﬁxed, permeabilized cells was performed using
an anti-KAHRP antibody diluted in blocking buffer. After labeling,
cells were re-suspended in PBS and allowed to attach to cover slips
coated with polylysine. The cover slips were mounted using Aqua-
Mount medium. Samples were imaged with a Zeiss 510 META confo-
cal microscope using a 100× oil objective.2.10. SDS-PAGE and Western blot
SDS-PAGE was performed in 10% acrylamide gels. Proteins were
transferred onto nitrocellulose membrane. After blocking for 1 h in
blocking buffer (10 mM Tris, pH 7.4, 150 mM NaCl, 0.5% Tween 20,
5% nonfat dry milk), the blot was probed for 1 h with the desired pri-
mary antibody (polyclonal anti-ankyrin R or anti-GST). After several
washes, the blot was incubated with an anti-rabbit IgG, coupled to
horseradish peroxidase (HRP). After ﬁnal washes, the blot was de-
veloped using the Renaissance chemiluminescence detection kit.
All steps were performed at room temperature.
3. Results
3.1. Association of malaria proteins with ankyrin R
We ﬁrst examined the binding of full length ankyrin R to frag-
ments of the exported malarial proteins, PfEMP3, PfEMP1, RESA,
and KAHRP using pulldown assays. All the recombinant polypeptides
of above mentioned malaria proteins were well characterized and
used in our previous published studies [14–16,24,25]. As a positive
control, we used repeats 14–15 of β-spectrin, a well-established
binder of ankyrin R [32]. A schematic representation of KAHRP struc-
ture and the recombinant fragments used in the present study is il-
lustrated in Fig. 1A-a. As shown in Fig. 1A-b, of the six GST-tagged
KAHRP fragments (K1A, K1B, K1C, K1D, K2, and K3), which encom-
pass the full-length of KAHRP, only GST-K1D pulled down ankyrin
R. The identiﬁcation of this one fragment was further conﬁrmed by
ELISA assay with immobilized ankyrin R (Fig. 1A-c). Ankyrin R did
not bind to any of the fragments of PfEMP3 (Fig. 1B-b), RESA (Fig. 1C-
b) or the cytoplasmic domain of PfEMP1 (Fig. 1D-b). The positive con-
trol, ankyrin R bound to repeats 14–15 of spectrin. Thus ankyrin R is a
binding partner for KAHRP on the erythrocytemembrane, and the bind-
ing site lies within the K1D region.
3.2. Mapping the KAHRP binding site in ankyrin R
A schematic representation of ankyrin R structure [33] and the re-
combinant fragments used in the present study are illustrated in
Fig. 2A. We used a similar pull-down approach to map the binding
site in this protein for KAHRP. Three recombinant MBP-tagged
ankyrin R domains (the 89 kDa membrane-binding domain (MBD),
the spectrin-binding domain and the C-terminal regulatory domain),
which encompass full-length ankyrin R, were puriﬁed and examined
for their ability to bind the K1D using both the MBP-pull-down assay
and ELISA. As shown in Fig. 2B-a, under the binding conditions used
in these experiments only theMBD fragment of ankyrin Rwas able to
pull down K1D. K1D did not bind to either of the other two domains
of ankyrin R. The selective binding of K1D to MBD is further con-
ﬁrmed by the ELISA assay which conﬁrms that only K1D binds to
immobilized MBD (Fig. 2B-b). Ankyrin R MBD domain is composed
of four subdomains termed D1, D2, D3 and D4. To further deﬁne
the KAHRP binding site in ankyrin R, the binding of GST-tagged
K1D to MBP-tagged D1, D2, D3, and D4 was examined. Fig. 2C-a
shows that only the D3 subdomain of ankyrin R was able to pull
down K1D. Consistent with this ﬁnding, as shown in Fig. 2C-b K1D
binds only to immobilized D3 by ELISA. Thus, we localized the
KAHRP binding site in ankyrin R to the D3 region within MBD of
ankyrin R.
3.3. Kinetic analysis of interactions between KAHRP and ankyrin R by
surface plasmon resonance assay
We used the active binding fragments determined above to ob-
tain kinetic binding data by surface plasmon resonance assay. In
these experiments, the GST-tagged K1D fragment of KAHRP was
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of its D3 subdomain was followed. As shown in Fig. 3, MBP-tagged
MBD and D3, but not MBP alone, bound to the immobilized K1D
(Fig. 3A). Fig. 3B and C demonstrates the dose-dependent binding
of MBD and D3 to Κ1D respectively. Curve ﬁtting of the sensograms
enabled us to derive the association and dissociation constants and
derive the binding afﬁnity values (Table 1). The binding afﬁnity forB
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well plate coatedwith ankyrin R. As shown in Fig. 4, the binding of K1D to
the intact protein decreased with increasing concentrations of ankyrin R
D3 fragment. At a concentration of 8 μM of D3, the binding between
ankyrin R and KAHRP was inhibited by 80%. MBP and MBP-tagged D2
fragments of ankyrin R had no inhibitory effect on the binding of the
K1D fragment to ankyrin R.
3.5. Effect of the ankyrin R D3 fragment on KAHRP localization in
malaria-infected erythrocytes
We have previously shown that the association of KAHRP with the
host cytoskeleton proteins is required for its proper assembly on the
erythrocyte membrane [16]. To establish the function of KAHRP–
ankyrin R interaction, we examined the localization of KAHRP in eryth-
rocytes, pre-loaded with free D3 ankyrin R fragment, and then exposed
to invasion by P. falciparum. Fig. 5A shows the membrane association of
KAHRP in resealed control erythrocytes infected by the parasite. The
same occurred when the resealed erythrocytes contained MBP
(Fig. 5B). In marked contrast, in cells containing MBP-D3 the KAHRP
showed only a diffuse distribution throughout the cytoplasm (Fig. 5C).Table 1
Binding afﬁnities between ankyrin R fragments to KAHRP fragment.
Ka(×104M−1 s−1) Kd(×10−3 s−1) KD(×10−8 M)
MBD–K1D 4.28 1.61 3.8
D3–K1D 2.99 1.37 4.6Uninfected erythrocytes showed no staining with an anti-KAHRP an-
tibody (data not shown). Thus sequestration of KAHRP by its free
ankyrin R-binding fragment prevents binding of the KAHRP to the
host cell membrane. We are aware that MBP is a large fusion tag
which could cause steric interference, but the ﬁnding that resealing
of MBP itself had no effect on the localization of KAHRP strongly sug-
gests that the altered localization of KAHRP in MBP-D3 resealed cells
is due to D3 but not MBP.
4. Discussion
In the present study, we performed a detailed molecular charac-
terization of the interaction between KAHRP and ankyrin R. We
showed that the association of the malaria protein KAHRP with the
host cytoskeleton protein ankyrin R is required for the attachment
of KAHRP to the red cell membrane. The importance of ankyrin R in
malaria infection is heighted by recent ﬁndings that the growth of ma-
laria parasite was impaired in ankyrin R mutant red cells [34,35]. Al-
though the mechanisms for the parasite growth retardation in ankyrin
Rmutant red cells remain largely unknown, it is possible that the defec-
tive KAHRP–ankyrin R association in these cells may contribute to this.
We have previously shown that KAHRP binds to α-spectrin repeat 4
[16], and this part of α-spectrin is close to the spectrin tetramerization
site. As ankyrin R binds to repeats 14–15 of β-spectrin which is also
close to the spectrin tetramerization site [32], this arrangement sug-
gests that it is possible for a single molecule of KAHRP to engage in sta-
bilizing two reactions at the membrane skeleton, one with ankyrin R
and onewith spectrin. It should be noted that while the binding afﬁnity
between KAHRP and α-spectrin is in the micromolar range [16], the
binding afﬁnity between KAHRP and ankyrin R is in the subnanomolar
range, suggesting that KAHRP association with the membrane in
infected erythrocytes may be dominantly regulated by ankyrin R.
Our earlier work also suggested an interaction between KAHRP
and ankyrin R, however it was based on indirect experiments in
which solubilized erythrocyte proteins were immunoprecipitated
with an anti-KAHRP antibody [23]. Such studies may identify spuri-
ous interactions by bringing together proteins that are not normally
associated. In that study we also used recombinant fragments in an
attempt to map interacting protein domains. The level of resolution
possible at the time was less than is available presently, neverthe-
less, we did suggest that the 89 kDa MBD of ankyrin R was involved
in the interaction with KAHRP. In our present study, using multiple
independent experimental approaches we conﬁrm that KAHRP and
ankyrin R do indeed interact and that this interaction resides within
the MBD of ankyrin R. One discrepancy between the two studies is
that we previously assigned the ankyrin R binding domain to the re-
peat region of the K2 fragment of KAHRP, a different conclusion from
the present study which assigns this binding domain to K1D. We
have no explanation for this discrepancy but we note that the afﬁnity
DD
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Control cells Cells resealed with MBP Cells resealed with MBP-D3
Fig. 5. Localization and distribution of KAHRP in erythrocytes infectedwith P. falciparum. Erythrocyteswere resealedwith no added proteins (A),with 40 μMMBP (B), orwith 40 μMMBP-
D3 (C). The resealed erythrocyteswere infectedwith P. falciparum and cultured for 48 h. The localization of KAHRPwas detected by immunostainingwith an anti-KAHRP antibody (green
color). The stained cells were imaged by confocal microscopy (100× objection).
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ﬁnity measured in the current study. Furthermore, in contrast to
the earlier study we performed an extensive series of studies to doc-
ument the speciﬁcity of the interaction between K1D fragment of
KAHRP and ankyrin R.
KAHRP is amajor component of the knob, an electron-dense protru-
sion located at the membrane of infected erythrocytes, the site of adhe-
sive interaction between infected erythrocytes and vascular endothelial
cells [36]. Although PfEMP1, the adhesive receptor expressed on the
surface of infected erythrocytes is responsible for adhesive interactions,
KAHRP by clustering PfEMP1 molecules markedly increases the avidity
of these adhesive interactions. Strong support for such a thesis comes
from the ﬁnding that that in the absence of KAHRP, infected erythro-
cytes adhere very weakly to endothelial cells under physiological ﬂow
conditions [37]. It has previously been suggested that PfEMP1 is an-
chored to the junctional complex through its direct interaction with
spectrin and actin or by its association with KAHRP [38,39]. Howev-
er, because the KAHRP binding site in spectrin is remote from the
spectrin–actin–protein 4.1R junctional complex and because
KAHRP does not bind to 4.1R (our unpublished data), we suggest
that the direct association of PfEMP1 and KAHRP probably occurs
at the ankyrin R complex rather than at the junctional complex.Fig. 6. Schematic representation of interactions between malaria proteins and host skeleton pr
which is near the center of the tetramer (dimer–dimer interaction site), PfEMP1 binds to KAH
spectrin. At the 4.1R-based macromolecular complex, PfEMP1 is anchored to the junctional co
spectrin, actin and 4.1R. MESA binds to the 30 kDa membrane domain of 4.1R.We further suggest that PfEMP1 may be anchored to the membrane
skeleton at both ankyrin R complex and 4.1R-complex. Based on the
previous ﬁndings and the ﬁndings from the present study, we propose
the current schematic model for the interactions between malaria pro-
teins and host skeleton proteins in the infected erythrocytes. Fig. 6 sum-
marizes the interactions. At the ankyrin R-based macromolecular
complex (which is close to spectrin tetramerization site), PfEMP1
binds to KAHRP which in turn binds to both ankyrin R and repeat 4 of
α-spectrin [16]. RESA binds to repeat 16 of β-spectrin and strengthens
the spectrin tetramer formation [14]. At the 4.1R-based macromolecu-
lar complex, PfEMP1 is anchored to the junctional complex through
its direct binding to spectrin, actin and 4.1R; PfEMP3 binds to the EF
hand domains of α-spectrin and interferes with the spectrin–actin–
4.1R ternary complex formation and destabilizes the membrane stabil-
ity [15]; MESA binds to the 30 kDa membrane domain of 4.1R [19]. It is
interesting to note that all identiﬁed associations centered around ei-
ther ankyrin R-based macromolecular complex or 4.1R-based macro-
molecular complex.
We have previously documented that spectrin plays an important
role in localizing KAHRP to the erythrocyte membrane. In the present
study, we show that ankyrin R plays a similar role. It appears that both
interactions are required as each can be separately inhibited by theoteins in malaria infected erythrocytes. At the ankyrin R-based macromolecular complex,
RP which in turn binds to both ankyrin R and α-spectrin. RESA binds to repeat 16 of β-
mplex through its direct binding to spectrin, actin and 4.1R. PfEMP3 also directly binds to
191H. Weng et al. / Biochimica et Biophysica Acta 1838 (2014) 185–192addition of an excess of ligand and in each case KAHRP mislocalizes. As
KAHRP is important for adherence of infected erythrocytes and adher-
ence of infected erythrocytes to vascular endothelium is a major deter-
minant of the pathogenicity of P. falciparum [40], we suggest that
reducing or eliminating adhesive interactions by interferingwith the in-
teraction of KAHRP with spectrin and ankyrin R is a potential therapeu-
tic strategy against malaria infection.
We and others have documented that the majority of characterized
associations between malaria proteins and the membrane of infected
red cells are mediated via interaction with spectrin. Unexpectedly, in
the present study we found that of the four spectrin-binding malaria
proteins (PfEMP1, PfEMP3, RESA and KAHRP), only KAHRP binds to
ankyrin R. These results suggest that spectrin is the major substrate
for localization of exported malarial proteins to the red cell membrane
skeleton and that spectrinmay serve as a scaffold for assembly ofmalar-
ia proteins in infected erythrocytes on the red cell membrane. However,
it should be noted that we could not exclude the possibility that the lack
of association of other malaria proteins with ankyrin R may be due to
some interactions require the cooperation of two domains being co-
expressed rather than one.
Previous studies have identiﬁed binding motifs involved in the
interactions between malaria proteins and erythrocyte membrane
proteins. For example, the 4.1R-binding site in MESA has been local-
ized to 19 residues located in the N-terminal region of MESA [18] and
a recent study further deﬁned similar erythrocyte cytoskeleton-binding
motif in a number of exported P. falciparum proteins including MESA
[41]. The spectrin-binding domain in RESA has been mapped to a 48-
residue region [42], whereas the spectrin-binding domain in MSP-1
has been localized to a 30-residue region [43]. We have identiﬁed the
reciprocal binding sites for malaria proteins on erythrocyte proteins.
For example, the MESA binding site on 4.1R has been mapped to a 51-
residue region encoded by exon 10 of the 4.1R gene [19]. The KAHRP,
PfEMP3 and RESA binding sites on spectrin have beenmapped to repeat
4 of α-spectrin, the EF hand domains of α-spectrin and repeat 16 of β-
spectrin respectively [14–16]. It is generally believed that the associa-
tions between a group of malaria proteins and erythrocyte proteins
are responsible for almost all the altered properties of parasitized eryth-
rocytes. It should be noted that according to proteomic analyses there
are at least 400 exported blood-stage P. falciparum proteins [1–3].
Thus identiﬁcation and characterization of these associations are still
far from complete. All of these interactions appear to be highly speciﬁc
and in at least some cases result in deﬁned alterations in mechanical
properties of infected cells. These studies have been performed in isola-
tion from each other andwe still await ﬁndings from future studies that
examine the simultaneous effects of multiple interacting domains on
red cell function.
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